4G/5G PAI-1 Promoter Polymorphism and Acute-Phase Levels of PAI-1 Following Coronary Bypass Surgery: A Prospective Study

2003 ◽  
Vol 16 (3) ◽  
pp. 149-154 ◽  
Author(s):  
Francesco Burzotta ◽  
Licia Iacoviello ◽  
Augusto Di Castelnuovo ◽  
Roberto Zamparelli ◽  
Andria D'Orazio ◽  
...  
Cardiology ◽  
2006 ◽  
Vol 108 (2) ◽  
pp. 82-89 ◽  
Author(s):  
Helen Sjöland ◽  
Lilian Tengborn ◽  
Lillemor Stensdotter ◽  
Johan Herlitz

1993 ◽  
Vol 70 (06) ◽  
pp. 0900-0902 ◽  
Author(s):  
D W T Nilsen ◽  
S M Almdahl ◽  
B Svensson ◽  
J Vaage ◽  
K Rasmussen ◽  
...  

SummaryTwenty patients with coronary heart disease (CHD) and elevated serum lipids were randomized into 2 groups of 10 to receive encapsulated preparations of either a concentrated ethylester form of eicosapentaenoic acid (EPA) and docosa-hexaenoic acid (DHA) or corn oil in doses of 6 g per day, given double blindly for approximately two months prior to coronary bypass surgery. Lipopolysaccharide (LPS) induced monocyte thromboplastin synthesis was studied during the preoperative period and one week following surgery. The ability of n-3 fatty acids to modify tissue factor pathway inhibitor (TFPI) and tissue plasminogen activator inhibitor (PAI-1) was also evaluated along with fibrinogen and thrombin-antithrombin III (TAT) complexes.No significant changes were noted preoperatively. Monocyte reactivity, PAI-1, fibrinogen and TAT increased significantly after surgery. These changes were not modified by preoperative loading with n-3 fatty acids.


2007 ◽  
Vol 104 (1) ◽  
pp. 51-58 ◽  
Author(s):  
John M. Murkin ◽  
Sandra J. Adams ◽  
Richard J. Novick ◽  
Mackenzie Quantz ◽  
Daniel Bainbridge ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document